1. Zhang Y, Zhang Q, Li H, Cong H*, Qu Y*. In vitro and in vivo anti-Toxoplasmaactivities of HDAC inhibitor Panobinostat on experimental acute ocular toxoplasmosis. Front Cell Infect Microbiol. 2022 Sep 12;12:1002817.
2. Wang Y, Han R, Xu Z, Sun X, Zhou C, Han B, He S*, Cong H*. Upregulation of ln cRNA147410.3 in the Brain of Mice With Chronic Toxoplasma Infection Promoted Micro glia Apoptosis by Regulating Hoxb3. Front Cell Neurosci. 2021 May 18;15:648047.
3.Sun X, Wang T, Wang Y, Ai K, Pan G, Li Y, Zhou C, He S and Cong H*. Downregulation of lncRNA-11496 in the Brain Contributes to Microglia Apoptosis via Regulation of Mef2c in Chronic T. gondii Infection Mice. Front Mol Neurosci. 2020；13:77.
4. Guo J, Zhou A, Sun X, Sha W, Ai K, Pan G, Zhou C, Zhou H, Cong H*, He S*.
Immunogenicity of a virus-like-particle vaccine containing multiple antigenic epitopes of Toxoplasma gondii against acute and chronic toxoplasmosis in mice. Front Immunol. 2019; 10:592.
5. Wang T＃, Sun X＃, Qin W, Zhang X, Wu L, Li Y, Zhou C, Zhou H, He S, Cong H*. From inflammatory reactions to neurotransmitter changes: Implications for understanding the neurobehavioral changes in mice chronically infected with Toxoplasma gondii. Behaviour Brain Res. 2019;359:737-748.
6. Guo J＃, Sun X＃, Yin H, Wang T, Li Y, Zhou C, Zhou H, He S*, Cong H*. Chitosan microsphere used as an effective system to deliver a linked antigenic peptides vaccine protect mice against acute and chronic Toxoplasmosis. Front Cell Infect Microbiol. 2018; 8:163.
7. Wang T＃, Yin H＃, Li Y＃, Zhao L, Sun X, Cong H*. Vaccination with recombinant adenovirus expressing multi-stage antigens of Toxoplasma gondii by the mucosal route induces higher systemic cellular and local mucosal immune responses than with other vaccination routes. Parasite. 2017; 24:12.
8. Yin H＃, Zhao L＃, Wang T, Zhou H, He S, Cong H*. A Toxoplasma gondii vaccine encoding multistage antigens in conjunction with ubiquitin confers protective immunity to BALB/c mice against parasite infection. Parasit Vectors. 2015;8(1):498.
9. Zhao L, Zhang M, Cong H*．Advances in the study of HLA-restricted epitope vaccines. Human Vaccines & Immunotherapeutics. 2014; 1:2566-77.
11. Zhang M, Zhao L, Song J, Li Y, Zhao Q, He S, Cong H*. DNA vaccine encoding the Toxoplasma gondii bradyzoite-specific surface antigens SAG2CDX protect BALB/c mice against type II parasite infection. Vaccine 2013; 31(41): 4536-40.
12. Cong H, Mui EJ, Witola WH, et al.Toxoplasma gondii HLA-B*0702-restricted GRA720-28 peptide with adjuvants and a universal helper T cell epitope elicits CD8+ T cells producing interferon-γ and reduces parasite burden in HLA-B* 0702 mice. Human immunology. 2012;73(1):1-10.
13. Cong H, Mui EJ, Witola WH, Sidney J, Alexander J, Sette A, Maewal A, McLeod R*. Towards an immunosense vaccine to prevent toxoplasmosis: protectiveToxoplasma gondiiepitopes restricted by HLA-A*0201.Vaccine. 2011;29(4):754-62.
14. Cong H, Mui EJ, Witola WH, Sidney J, Alexander J, Sette A, Maewal A, McLeod R*. Human immunome, bioinformatic analyses using HLA supermotifs and the parasite genome, binding assays, studies of human T cell responses, and immunization of HLA-A*1101 transgenic mice including novel adjuvants provide a foundation for HLA-A03 restricted CD8+T cell epitope based, adjuvanted vaccine protective againstToxoplasma gondii.Immunome Res. 2010;6:12.
15. Cong H,Gu QM*,Yin HE,Wang JW,ZhaoQL,Zhou HY,Li Y,Zhang JQ. Multi-epitope DNA vaccine linked to the A2/B subunit of cholera toxin protect mice against Toxoplasma gondii.Vaccine. 2008;26(31):3913-21.
16. Cong H, Gu QM, Jiang Y, He SY, Zhou HY, Yang TT, Li Y, Zhao QL.Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice againstToxoplasma gondii.Parasite Immunol. 2005;27(1-2):29-35.
授权发明专利:
1. lncRNA11496在诊治弓形虫病中的应用 2021.2.5 中国 ZL201910299793.4
2. 一种弓形虫GRA10复合表位肽及其制备的疫苗 2018.7.03 中国 ZL201510563797.0
3. 一种用于预防弓形虫病的多价腺病毒疫苗 2017.1.11 中国ZL201410345709.5
4. 基于弓形虫缓殖子抗原的CD8+T细胞优势表位 2016.9.4 中国 ZL201310204200.4
5. 用于预防人或动物慢性弓形虫病的DNA疫苗 2016.8.21 中国 ZL201310201888.0
